Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07


Por: Isla D, Felip E, Viñolas N, Provencio M, Majem M, Artal A, Bover I, Lianes P, DE Las Peñas R, Catot S, DE Castro J, Blasco A, Terrasa J, Gonzalez-Larriba JL, Juan O, Dómine M, Bernabe R, Garrido P

Publicada: 1 dic 2016
Resumen:
Background: The WORLD07 project is a female specific database to prospectively analyze the characteristics of Spanish women with lung cancer. Patients and Methods: We analyzed and compared lung cancer features in women with and without a family history of cancer/lung cancer. Results: Two thousand and sixty women were included: 876 had a family history of cancer (lung cancer, 34%) and 886 did not, with no significant differences between groups, except for smoking status (p=0.036). We found statistically significant correlations between epidermal growth factor receptor (EGFR) mutation and smoking status in patients with a family history of cancer (r=-0.211; p<0.001) and lung cancer (r=-0.176; p<0.001). Longer median overall survival was observed in women with a family history of cancer and lung cancer. Conclusion: Among Spanish women with lung cancer, a greater proportion were current smokers in those with a family history of cancer/lung cancer. There was a significant correlation between the presence of EGFR mutation and smoking.

Filiaciones:
Isla D:
 Medical Oncology Department, Instituto de Investigación Sanitaria Aragón, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain

Felip E:
 Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain

Viñolas N:
 Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain

Provencio M:
 Medical Oncology Department, Hospital Clínic, Barcelona, Spain

Majem M:
 Medical Oncology Department, Hospital Puerta de Hierro, Madrid, Spain

Artal A:
 Medical Oncology Department, Hospital Sant Pau, Barcelona, Spain

Bover I:
 Medical Oncology Department, Hospital Son Llátzer, Palma de Mallorca, Spain

Lianes P:
 Medical Oncology Department, Hospital de Mararó, Barcelona, Spain

DE Las Peñas R:
 Medical Oncology Department, Consorcio Hospital Provincial de Castellón, Castellón De La Plana, Spain

Catot S:
 Medical Oncology Department, Althaia Xarxa Assistencial Universitaria de Manresa, Manresa, Spain

DE Castro J:
 Medical Oncology Department, Hospital La Paz, Madrid, Spain

Blasco A:
 Medical Oncology Department, Hospital General de Valencia, Valencia, Spain

Terrasa J:
 Medical Oncology Department, Hospital Son Espases, Palma de Mallorca, Spain

Gonzalez-Larriba JL:
 Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain

Juan O:
 Medical Oncology Department, Hospital La Fe, Valencia, Spain

Dómine M:
 Medical Oncology Department, Fundación Jiménez Díaz, Madrid, Spain

Bernabe R:
 Medical Oncology Department, Hospital Nuestra Señora de Valme, Sevilla, Spain

Garrido P:
 Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain
ISSN: 02507005





Anticancer Research
Editorial
INT INST ANTICANCER RESEARCH, EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE, Grecia
Tipo de documento: Article
Volumen: 36 Número: 12
Páginas: 6647-6653
WOS Id: 000390946700059
ID de PubMed: 27919997

MÉTRICAS